MedTrace Logo

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

NCT07083583 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-10-03

No results posted yet for this study

Summary

This is a prospective, single-arm, single-center observational study evaluating the impact of intravenous (IV) iron replacement in patients with inherited bleeding disorders and iron deficiency (ferritin \<50ng/dL). Subjects will undergo baseline bleeding assessments, quality-of-life measures, and laboratory tests before receiving standard-of-care IV iron. Follow-up blood work and questionnaires will be conducted post-replacement to assess for changes

Conditions

Interventions

DRUG

IV Iron (standard of care)

Participants will receive IV iron therapy as part of standard management for iron deficiency

Sponsors & Collaborators

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • Nicoletta C Machin

    lead OTHER

Principal Investigators

  • Nicoletta Machin, DO · University of Pittburgh

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-08
Primary Completion
2027-10-01
Completion
2027-10-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07083583 on ClinicalTrials.gov